Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 10.23 is 85% above its 1-year average of 5.54, near the high end of its 1-year range (2.37–10.23).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.23.
QUICK RATIO (ACID-TEST)
10.23
QUICK RATIO (ACID-TEST) AVG TTM
N/A
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.85
median of 440 covered companies
CURRENT VS SECTOR MEDIAN
+258.87%
vs the sector median at left
Alamar Biosciences, Inc.
Market Cap
$2.64B
Quick Ratio (Acid-Test)
10.23
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.64B
Quick Ratio (Acid-Test)
14.57
TTM Avg
8.96
3Y Avg
7.17
5Y Avg
6.28
Market Cap
$2.69B
Quick Ratio (Acid-Test)
1.56
TTM Avg
1.27
3Y Avg
1.12
5Y Avg
1.27
Market Cap
$2.69B
Quick Ratio (Acid-Test)
1.16
TTM Avg
1.32
3Y Avg
1.06
5Y Avg
0.97
Market Cap
$2.51B
Quick Ratio (Acid-Test)
5.03
TTM Avg
4.66
3Y Avg
4.92
5Y Avg
7.11
Market Cap
$2.43B
Quick Ratio (Acid-Test)
1.50
TTM Avg
1.54
3Y Avg
1.54
5Y Avg
1.56
Market Cap
$2.87B
Quick Ratio (Acid-Test)
6.07
TTM Avg
7.05
3Y Avg
8.10
5Y Avg
8.04
Market Cap
$2.88B
Quick Ratio (Acid-Test)
12.02
TTM Avg
18.93
3Y Avg
12.46
5Y Avg
15.83
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alamar Biosciences, Inc. (ALMR) | $2.64B | 10.23 | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | 14.57 | 8.96 | 7.17 | 6.28 |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 1.56 | 1.27 | 1.12 | 1.27 |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 1.16 | 1.32 | 1.06 | 0.97 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.51B | 5.03 | 4.66 | 4.92 | 7.11 |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | 1.50 | 1.54 | 1.54 | 1.56 |
| AtriCure, Inc. (ATRC)vs › | $2.87B | 3.19 | 2.81 | 2.79 | 3.25 |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 6.07 | 7.05 | 8.10 | 8.04 |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | 12.02 | 18.93 | 12.46 | 15.83 |
| ADMA Biologics, Inc. (ADMA)vs › | $2.34B | 3.81 | 3.32 | 2.77 | 2.91 |
Quick Ratio
10.23
Excludes inventory
Current Ratio
11.85
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 10.23 |
| 2026-03-31 | 4.02 |
| 2025-12-31 | 2.37 |
